{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T01:01:06Z","timestamp":1783472466460,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,4,8]],"date-time":"2015-04-08T00:00:00Z","timestamp":1428451200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12882-015-0043-3","type":"journal-article","created":{"date-parts":[[2015,4,7]],"date-time":"2015-04-07T20:08:35Z","timestamp":1428437315000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Pharmacokinetics of nalbuphine hydrochloride extended release tablets in hemodialysis patients with exploratory effect on pruritus"],"prefix":"10.1186","volume":"16","author":[{"given":"Amale","family":"Hawi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Harry","family":"Alcorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolene","family":"Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carey","family":"Hines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Hait","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Sciascia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,8]]},"reference":[{"issue":"8","key":"43_CR1","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.2215\/CJN.00100110","volume":"5","author":"VS Mathur","year":"2010","unstructured":"Mathur VS, Lindberg J, Germain M, Block G, Tumlin J, Smith M, et al. A longitudinal study of uremic pruritus in hemodialysis patients. Clin J Am Soc Nephrol. 2010;5(8):1410\u20139.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"43_CR2","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.1093\/ndt\/gfl461","volume":"21","author":"RL Pisoni","year":"2006","unstructured":"Pisoni RL, Wikstrom B, Elder SJ, Akizawa T, Asano Y, Keen ML, et al. Pruritus in haemodialysis patients: International results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2006;21(12):3495\u2013505.","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"43_CR3","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1038\/sj.ki.5000251","volume":"69","author":"I Narita","year":"2006","unstructured":"Narita I, Alchi B, Omori K, Sato F, Ajiro J, Saga D, et al. Etiology and prognostic significance of severe uremic pruritus in chronic hemodialysis patients. Kidney Int. 2006;69(9):1626\u201332.","journal-title":"Kidney Int"},{"issue":"3","key":"43_CR4","doi-asserted-by":"publisher","first-page":"251","DOI":"10.2165\/00003495-200969030-00002","volume":"69","author":"L Manenti","year":"2009","unstructured":"Manenti L, Tansinda P, Vaglio A. Uraemic pruritus: clinical characteristics, pathophysiology and treatment. Drugs. 2009;69(3):251\u201363.","journal-title":"Drugs"},{"issue":"2","key":"43_CR5","first-page":"1","volume":"15","author":"M Mettang","year":"2010","unstructured":"Mettang M, Weisshaar E. Pruritus: control of itch in patients undergoing dialysis. Skin Therapy Lett. 2010;15(2):1\u20135.","journal-title":"Skin Therapy Lett"},{"key":"43_CR6","doi-asserted-by":"crossref","unstructured":"Mettang T, Kremer AE: Uremic pruritus. Kidney Int 2014. Jan 8. doi:10.1038\/ki.2013.454.","DOI":"10.1038\/ki.2013.454"},{"issue":"4","key":"43_CR7","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1159\/000077841","volume":"208","author":"E Legroux-Crespel","year":"2004","unstructured":"Legroux-Crespel E, Cledes J, Misery L. A comparative study on the effects of naltrexone and loratadine on uremic pruritus. Dermatology. 2004;208(4):326\u201330.","journal-title":"Dermatology"},{"issue":"1","key":"43_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1053\/j.ajkd.2007.03.010","volume":"50","author":"TS Patel","year":"2007","unstructured":"Patel TS, Freedman BI, Yosipovitch G. An update on pruritus associated with CKD. Am J Kidney Dis. 2007;50(1):11\u201320.","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"43_CR9","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1172\/JCI28553","volume":"116","author":"R Paus","year":"2006","unstructured":"Paus R, Schmelz M, Biro T, Steinhoff M. Frontiers in pruritus research: scratching the brain for more effective itch therapy. J Clin Invest. 2006;116(5):1174\u201386.","journal-title":"J Clin Invest"},{"issue":"1","key":"43_CR10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ejphar.2003.08.007","volume":"477","author":"H Umeuchi","year":"2003","unstructured":"Umeuchi H, Togashi Y, Honda T, Nakao K, Okano K, Tanaka T, et al. Involvement of central mu-opioid system in the scratching behavior in mice, and the suppression of it by the activation of kappa-opioid system. Eur J Pharmacol. 2003;477(1):29\u201335.","journal-title":"Eur J Pharmacol"},{"key":"43_CR11","volume-title":"Itch, Basic Mechanisms and Therapy","author":"H Kumagai","year":"2004","unstructured":"Kumagai H, Saruta T, Matsukawa S, Utsumi J. Prospects for a novel kappa-opioid receptor agonist, TRK-820, in uremic pruritus. In: Itch, Basic Mechanisms and Therapy. New York: Marcel Dekker Inc; 2004."},{"issue":"3","key":"43_CR12","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/S0165-6147(98)01169-9","volume":"19","author":"ZZ Pan","year":"1998","unstructured":"Pan ZZ. mu-Opposing actions of the kappa-opioid receptor. Trends Pharmacol Sci. 1998;19(3):94\u20138.","journal-title":"Trends Pharmacol Sci"},{"issue":"4","key":"43_CR13","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/j.1529-8019.2005.00039.x","volume":"18","author":"M Schmelz","year":"2005","unstructured":"Schmelz M. Itch and pain. Dermatol Ther. 2005;18(4):304\u20137.","journal-title":"Dermatol Ther"},{"issue":"4","key":"43_CR14","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1093\/ndt\/gfp588","volume":"25","author":"H Kumagai","year":"2010","unstructured":"Kumagai H, Ebata T, Takamori K, Muramatsu T, Nakamoto H, Suzuki H. Effect of a novel kappa-receptor agonist, nalfurafine hydrochloride, on severe itch in 337 haemodialysis patients: a Phase III, randomized, double-blind, placebo-controlled study. Nephrol Dial Transplant. 2010;25(4):1251\u20137.","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"43_CR15","doi-asserted-by":"publisher","first-page":"3742","DOI":"10.1681\/ASN.2005020152","volume":"16","author":"B Wikstrom","year":"2005","unstructured":"Wikstrom B, Gellert R, Ladefoged SD, Danda Y, Akai M, Ide K, et al. Kappa-opioid system in uremic pruritus: multicenter, randomized, double-blind, placebo-controlled clinical studies. J Am Soc Nephrol. 2005;16(12):3742\u20137.","journal-title":"J Am Soc Nephrol"},{"issue":"9041","key":"43_CR16","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1016\/S0140-6736(96)04176-1","volume":"348","author":"G Peer","year":"1996","unstructured":"Peer G, Kivity S, Agami O, Fireman E, Silverberg D, Blum M, et al. Randomised crossover trial of naltrexone in uraemic pruritus. Lancet. 1996;348(9041):1552\u20134.","journal-title":"Lancet"},{"key":"43_CR17","first-page":"599","volume-title":"The pharmacologic basis of therapeutics","author":"H Gutstein","year":"2001","unstructured":"Gutstein H, Akil H. Chapter 23: Opioid analgesics. In: The pharmacologic basis of therapeutics. 10th ed. New York, NY: McGraw Hill; 2001. p. 599.","edition":"10"},{"key":"43_CR18","unstructured":"Nalbuphine HCl Injection Solution. Labelling Information, Hospira, Inc. Lake Forest, IL. October 2007."},{"issue":"5","key":"43_CR19","first-page":"747","volume":"75","author":"SE Cohen","year":"1992","unstructured":"Cohen SE, Ratner EF, Kreitzman TR, Archer JH, Mignano LR. Nalbuphine is better than naloxone for treatment of side effects after epidural morphine. Anesth Analg. 1992;75(5):747\u201352.","journal-title":"Anesth Analg"},{"issue":"2","key":"43_CR20","first-page":"172","volume":"34","author":"CC Liao","year":"2011","unstructured":"Liao CC, Chang CS, Tseng CH, Sheen MJ, Tsai SC, Chang YL, et al. Efficacy of intramuscular nalbuphine versus diphenhydramine for the prevention of epidural morphine-induced pruritus after cesarean delivery. Chang Gung Med J. 2011;34(2):172\u20138.","journal-title":"Chang Gung Med J"},{"issue":"3","key":"43_CR21","first-page":"214","volume":"21","author":"JJ Wang","year":"1996","unstructured":"Wang JJ, Ho ST, Hu OY. Comparison of intravenous nalbuphine infusion versus saline as an adjuvant for epidural morphine. Reg Anesth. 1996;21(3):214\u20138.","journal-title":"Reg Anesth"},{"issue":"5","key":"43_CR22","first-page":"479","volume":"23","author":"JJ Wang","year":"1998","unstructured":"Wang JJ, Ho ST, Tzeng JI. Comparison of intravenous nalbuphine infusion versus naloxone in the prevention of epidural morphine-related side effects. Reg Anesth Pain Med. 1998;23(5):479\u201384.","journal-title":"Reg Anesth Pain Med"},{"issue":"5","key":"43_CR23","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1213\/00000539-199311000-00009","volume":"77","author":"B Wittels","year":"1993","unstructured":"Wittels B, Glosten B, Faure EA, Moawad AH, Ismail M, Hibbard J, et al. Opioid antagonist adjuncts to epidural morphine for postcesarean analgesia: maternal outcomes. Anesth Analg. 1993;77(5):925\u201332.","journal-title":"Anesth Analg"},{"key":"43_CR24","first-page":"S634","volume":"93","author":"A Hawi","year":"2013","unstructured":"Hawi A, Hunter R, Morford L, Sciascia T. Nalbuphine attenuates itch in the Substance-P induced mouse model. Acta Derm Venereol. 2013;93:S634.","journal-title":"Acta Derm Venereol"},{"key":"43_CR25","unstructured":"Johnson SJ. Opioid safety in patients with renal or hepatic dysfunction. In: Pain Treatment Topics. 2007. http:\/\/paincommunity.org\/blog\/wp-content\/uploads\/Opioids-Renal-Hepatic-Dysfunction.pdf."},{"issue":"1","key":"43_CR26","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jpain.2003.09.007","volume":"5","author":"S Mercadante","year":"2004","unstructured":"Mercadante S, Arcuri E. Opioids and renal function. J Pain. 2004;5(1):2\u201319.","journal-title":"J Pain"},{"issue":"7","key":"43_CR27","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/S0025-6196(11)60750-7","volume":"84","author":"HS Smith","year":"2009","unstructured":"Smith HS. Opioid metabolism. Mayo Clin Proc. 2009;84(7):613\u201324.","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"43_CR28","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/j.1365-2125.1988.tb03300.x","volume":"25","author":"AR Aitkenhead","year":"1988","unstructured":"Aitkenhead AR, Lin ES, Achola KJ. The pharmacokinetics of oral and intravenous nalbuphine in healthy volunteers. Br J Clin Pharmacol. 1988;25(2):264\u20138.","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"43_CR29","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/clpt.1989.130","volume":"46","author":"P Jaillon","year":"1989","unstructured":"Jaillon P, Gardin ME, Lecocq B, Richard MO, Meignan S, Blondel Y, et al. Pharmacokinetics of nalbuphine in infants, young healthy volunteers, and elderly patients. Clin Pharmacol Ther. 1989;46(2):226\u201333.","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"43_CR30","doi-asserted-by":"publisher","first-page":"191","DOI":"10.2165\/00003495-198326030-00002","volume":"26","author":"JK Errick","year":"1983","unstructured":"Errick JK, Heel RC. Nalbuphine. A preliminary review of its pharmacological properties and therapeutic efficacy. Drugs. 1983;26(3):191\u2013211.","journal-title":"Drugs"},{"issue":"3\u20134","key":"43_CR31","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/0376-8716(85)90066-3","volume":"14","author":"WK Schmidt","year":"1985","unstructured":"Schmidt WK, Tam SW, Shotzberger GS, Smith Jr DH, Clark R, Vernier VG. Nalbuphine. Drug Alcohol Depend. 1985;14(3\u20134):339\u201362.","journal-title":"Drug Alcohol Depend"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-015-0043-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-015-0043-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-015-0043-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-015-0043-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T10:42:27Z","timestamp":1630579347000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-015-0043-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,8]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["43"],"URL":"https:\/\/doi.org\/10.1186\/s12882-015-0043-3","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,8]]},"assertion":[{"value":"15 August 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"47"}}